- Home
- CRON vs ALVO Comparison
CRON vs ALVO Comparison
Compare CRON & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRON | ALVO |
|---|---|---|
| Founded | N/A | 2013 |
| Country | Canada | Luxembourg |
| Employees | N/A | 1460 |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 985.8M | 1.1B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRON | ALVO |
|---|---|---|
| Price | $2.73 | $3.42 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 1.4M | 387.3K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $146,587,000.00 | N/A |
| Revenue This Year | $26.34 | $13.28 |
| Revenue Next Year | $15.53 | $18.63 |
| P/E Ratio | $68.38 | ★ $18.20 |
| Revenue Growth | ★ 24.63 | N/A |
| 52 Week Low | $1.84 | $3.03 |
| 52 Week High | $3.43 | $11.85 |
Technical Indicators
Market Signals| Indicator | CRON | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 55.88 | 49.49 |
| Support Level | $2.44 | $3.13 |
| Resistance Level | $2.83 | $3.83 |
| Average True Range (ATR) | 0.10 | 0.19 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 45.69 | 45.13 |
Price Performance
Historical ComparisonAbout CRON Cronos Group Inc.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
About ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.